Abstract
High-dose chemotherapy (HDCT) followed by autologous blood cell (ABC) transplantation has been used widely for patients with metastatic breast cancer (MBC). It has been shown by our group and others to be an effective means of achieving very high response rates including complete remission. Therefore, further reduction in toxicity and increased patient satisfaction is necessary. Fifty-three patients with MBC were enrolled in a feasibility study at our cancer centre with a three-step approach to outpatient observation after HDCT and ABC transplantation discharging our patients from hospital 6 days after reinfusion of ABC, 1 day after reinfusion of ABC and 1 day prior to reinfusion of ABC. The supportive care consisted of the use of 5-HT3 antagonists for nausea and vomiting, DMSO depletion, thorough body hygiene, prophylactic antibiotic, antifungal and virustatic drugs. In the event of febrile neutropenia, a standard evaluation and treatment was used. Only 22 patients were admitted for febrile neutropenia and two for haemorrhage. The median hospital stay was 2 days (range 1–7). The time to engraftment, need for transfusion and other toxicities were not different in patients who stayed entirely as outpatients. No toxic deaths occurred. In conclusion, HDCT followed by ABC transplantation can be safely administered to patients in the clinic with outpatient post-transplant observation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Glück, S., Rochers, C., Cano, C. et al. High-dose chemotherapy followed by autologous blood cell transplantation: a safe and effective outpatient approach. Bone Marrow Transplant 20, 431–434 (1997). https://doi.org/10.1038/sj.bmt.1700901
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700901
Keywords
This article is cited by
-
Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma
Bone Marrow Transplantation (2015)
-
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs
Bone Marrow Transplantation (2012)
-
Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes
Bone Marrow Transplantation (2010)
-
Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM
Bone Marrow Transplantation (2010)
-
Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma
Annals of Hematology (2006)